Loading...

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.

GSE135350 XPO1 inhibition Dexamethasone 3 v 1 human dn (Gene Set)

Genes: 1,716

Description: A gene set from rummageo gene perturbations provided by LINCS

Label	Description
SMARCA5 Gene (Entity type)	SNF2 related chromatin remodeling ATPase 5
H3-3A Gene (Entity type)	H3.3 histone A
CHRNA5 Gene (Entity type)	cholinergic receptor nicotinic alpha 5 subunit
SNHG16 Gene (Entity type)	small nucleolar RNA host gene 16
CPAP Gene (Entity type)	centrosome assembly and centriole elongation protein
CHRNA9 Gene (Entity type)	cholinergic receptor nicotinic alpha 9 subunit
NAA10 Gene (Entity type)	N-alpha-acetyltransferase 10, NatA catalytic subunit
POMP Gene (Entity type)	proteasome maturation protein
NDUFB9 Gene (Entity type)	NADH:ubiquinone oxidoreductase subunit B9
SGO1 Gene (Entity type)	shugoshin 1

DISPLAY PER PAGE